{
    "clinical_study": {
        "@rank": "102427", 
        "arm_group": [
            {
                "arm_group_label": "Oral Azithromycin", 
                "arm_group_type": "Experimental", 
                "description": "Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days."
            }, 
            {
                "arm_group_label": "Doxycycline", 
                "arm_group_type": "Active Comparator", 
                "description": "Oral doxycycline 100mg capsule every 12 hours for one month"
            }
        ], 
        "brief_summary": {
            "textblock": "One hundred patients with the diagnosis of posterior blepharitis based on history taking and\n      proper physical examinations by two experienced ophthalmologists will include in the study.\n\n      Patients will diagnose with posterior blepharitis if they score at least one in two symptoms\n      (based on a subjective grading scale) and two signs (based on an objective grading scale) of\n      posterior blepharitis according to study criteria. Patients will exclude if they have the\n      following criteria: age< 12 years old,history of previous ocular or lacrimal\n      surgery,previous usage of contact lenses,any history of ocular allergy,history of systemic\n      diseases with ocular involvement (except rosacea), history of usage of topical or systemic\n      antibiotic  in the last month, pregnancy or lactating mothers, liver failure and any history\n      of sensitivity to cyclines.\n\n      Qualified patients then randomly receive oral azithromycin (2 of 250 mg capsules for the\n      first day and 250mg for the next 4 days) or oral doxycycline (100mg capsule every 12 hours\n      for one month) in a double-blinded fashion. each patients in both treatment  groups will\n      accurately instruct to apply warm compress and eyelid scrubbing 2 times a day for 5 minutes\n      each in the treatment period. Symptoms and signs  were recorded for each patient in two\n      treatment groups at baseline visit (before treatment) and then in the days 7, 31, 37 and 61\n      after treatment."
        }, 
        "brief_title": "Oral Azithromycin Versus Doxycycline in Posterior Blepharitis", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Oral doxycycline 100mg capsule every 12 hours for one month\nDoxycycline :", 
                            "title": "Doxycycline"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.\nAzithromycin :", 
                            "title": "Oral Azithromycin"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "50"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "50"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "100"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "6"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "46"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "43"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "89"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "2"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "3"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "5"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "24"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "26"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "50"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "26"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "24"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "50"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "50"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "50"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "100"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "Iran, Islamic Republic of"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "t-test, 1 sided", 
                                "non_inferiority": "No", 
                                "p_value": "0.03"
                            }
                        }, 
                        "description": "Five main ocular symptoms of posterior blepharitis (itching, foreign body sensation, dryness, burning, and lid swelling) will be asked of each patient and graded at baseline, and days 7, 31, 37 and 61 after treatment.  For each item there was a question with scale from zero to three (zero for no symptom three for maximum symptom). Therefore, maximum score for symptoms was 15 (worse outcome) and minimum score for symptoms was zero (better outcome). Finally, we reported a change in total score calculated as the latest time point (61 days) minus the earliest time point.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Oral doxycycline 100mg capsule every 12 hours for one month\nDoxycycline :", 
                                    "title": "Doxycycline"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.\nAzithromycin :", 
                                    "title": "Oral Azithromycin"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "50"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "50"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.5", 
                                                        "@value": "1.8"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "2.2", 
                                                        "@value": "2.8"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Five main ocular symptoms of posterior blepharitis (itching, foreign body sensation, dryness, burning, and lid swelling) will be asked of each patient and graded at baseline, and days 7, 31, 37 and 61 after treatment.  For each item there was a question with scale from zero to three (zero for no symptom three for maximum symptom). Therefore, maximum score for symptoms was 15 (worse outcome) and minimum score for symptoms was zero (better outcome). Finally, we reported a change in total score calculated as the latest time point (61 days) minus the earliest time point.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change of Blepharitis Symptoms Score", 
                                    "units": "score"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Change from the baseline until 61 days after treatment", 
                        "title": "Change of Blepharitis Symptoms Score", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "t-test, 1 sided", 
                                "non_inferiority": "No", 
                                "p_value": "0.01"
                            }
                        }, 
                        "description": "lid margin debris, lid margin redness, Meibomian gland (MG) secretion, occluded MG, conjunctival redness, tear brake up time and ocular surface staining at Baseline, and days 7, 31, 37 and 61 after treatment were measured.  For each items there was a question with scale form zero to three (zero for no sign to three for maximum sign). Therefore, maximum score for signs was 21 (worse outcome) and minimum score was zero (better outcome). We calculated a total score for signs. Finally, we reported a change in total score calculated as the latest time point (61 days) minus earliest time point.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Oral doxycycline 100mg capsule every 12 hours for one month\nDoxycycline :", 
                                    "title": "Doxycycline"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.\nAzithromycin :", 
                                    "title": "Oral Azithromycin"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "50"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "50"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.3", 
                                                        "@value": "4.7"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "2.0", 
                                                        "@value": "5.7"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "lid margin debris, lid margin redness, Meibomian gland (MG) secretion, occluded MG, conjunctival redness, tear brake up time and ocular surface staining at Baseline, and days 7, 31, 37 and 61 after treatment were measured.  For each items there was a question with scale form zero to three (zero for no sign to three for maximum sign). Therefore, maximum score for signs was 21 (worse outcome) and minimum score was zero (better outcome). We calculated a total score for signs. Finally, we reported a change in total score calculated as the latest time point (61 days) minus earliest time point.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Main Ocular Signs", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "Change from baseline until 61 days after treatment", 
                        "title": "Main Ocular Signs", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "t-test, 1 sided", 
                                "non_inferiority": "No", 
                                "p_value": "0.007"
                            }
                        }, 
                        "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (61 days) minus earliest time point.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Oral doxycycline 100mg capsule every 12 hours for one month\nDoxycycline :", 
                                    "title": "Doxycycline"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.\nAzithromycin :", 
                                    "title": "Oral Azithromycin"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "50"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "50"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "4.1", 
                                                        "@value": "6.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "3.6", 
                                                        "@value": "8.6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (61 days) minus earliest time point.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change of Symptoms and Signs Scores (Difference Between Total Score of First Time and 61 Days Later), Total Severity Score", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "zero time and 61 days later", 
                        "title": "Change of Symptoms and Signs Scores (Difference Between Total Score of First Time and 61 Days Later), Total Severity Score", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "t-test, 1 sided", 
                                "non_inferiority": "No", 
                                "p_value": "> 0.05"
                            }
                        }, 
                        "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (7 days) minus earliest time point.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Oral doxycycline 100mg capsule every 12 hours for one month\nDoxycycline :", 
                                    "title": "Doxycycline"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.\nAzithromycin :", 
                                    "title": "Oral Azithromycin"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "50"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "50"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.5", 
                                                        "@value": "3.9"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "2.6", 
                                                        "@value": "4.3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (7 days) minus earliest time point.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change of Total Severity Score Between Baseline and 7 Days Later", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "baseline and 7 days later", 
                        "title": "Change of Total Severity Score Between Baseline and 7 Days Later", 
                        "type": "Other Pre-specified"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "t-test, 1 sided", 
                                "non_inferiority": "No", 
                                "p_value": "0.02"
                            }
                        }, 
                        "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (31 days) minus earliest time point.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Oral doxycycline 100mg capsule every 12 hours for one month\nDoxycycline :", 
                                    "title": "Doxycycline"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.\nAzithromycin :", 
                                    "title": "Oral Azithromycin"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "50"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "50"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "2.4", 
                                                        "@value": "5.2"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "2.6", 
                                                        "@value": "6.4"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (31 days) minus earliest time point.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change of Total Severity Score Between Baseline and 31 Days Later", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "baseline and 31 days later", 
                        "title": "Change of Total Severity Score Between Baseline and 31 Days Later", 
                        "type": "Other Pre-specified"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": {
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "t-test, 1 sided", 
                                "non_inferiority": "No", 
                                "p_value": "0.08"
                            }
                        }, 
                        "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (37 days) minus earliest time point.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Oral doxycycline 100mg capsule every 12 hours for one month\nDoxycycline :", 
                                    "title": "Doxycycline"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.\nAzithromycin :", 
                                    "title": "Oral Azithromycin"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "50"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "50"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "3.2", 
                                                        "@value": "6.3"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "3", 
                                                        "@value": "7.4"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (37 days) minus earliest time point.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Change of Total Severity Score Between Baseline and 37 Days Later", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "baseline and 37 days later", 
                        "title": "Change of Total Severity Score Between Baseline and 37 Days Later", 
                        "type": "Other Pre-specified"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Oral doxycycline 100mg capsule every 12 hours for one month\nDoxycycline :", 
                            "title": "Doxycycline"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.\nAzithromycin :", 
                            "title": "Oral Azithromycin"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "50", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "50", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "50", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "50", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "Patients were excluded if they had: age< 12 years,history of ocular or lacrimal surgery,previous usage of contact lenses,history of ocular allergy or systemic diseases with ocular involvement, history of usage of topical or systemic antibiotic  in the last month, pregnant or lactating mothers, liver failure and history of sensitivity to Cyclines.", 
                "recruitment_details": "All 100 patients were selected from the eye clinic of Rasoule-Akram hospital during the study period. The patients were recruited sequentially."
            }, 
            "point_of_contact": {
                "email": "bahmanik@eyeplasticsurgeries.com", 
                "name_or_title": "Dr. Mohsen Bahmani-Kashkouli", 
                "organization": "Rasoule-Akram Hospital", 
                "phone": "00982166558811"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Oral doxycycline 100mg capsule every 12 hours for one month\nDoxycycline :", 
                            "title": "Doxycycline"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Two 250 mg capsules (500 mg) of Azithromycin for the first day and 250mg/day for the next 4 days.\nAzithromycin :", 
                            "title": "Oral Azithromycin"
                        }
                    ]
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "12", 
                                                "@subjects_at_risk": "50"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "50"
                                            }
                                        ], 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "12", 
                                                "@subjects_at_risk": "50"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "50"
                                            }
                                        ], 
                                        "sub_title": "vomiting and loss of appetide"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment"
                }
            }
        }, 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Posterior Blepharitis", 
        "condition_browse": {
            "mesh_term": "Blepharitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patients were diagnosed with posterior blepharitis if they scored at least one in two\n        symptoms (based on a subjective grading scale) and two signs (based on an objective\n        grading scale) of posterior blepharitis according to study criteria\n\n        Exclusion Criteria:\n\n        Patients were excluded if they had the following criteria: age< 12 years old,history of\n        previous ocular or lacrimal surgery,previous usage of contact lenses,any history of ocular\n        allergy,history of systemic diseases with ocular involvement (except rosacea), history of\n        usage of topical or systemic antibiotic  in the last month, pregnancy or lactating\n        mothers, liver failure and any history of sensitivity to cyclines"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "13 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 1, 2013", 
        "firstreceived_results_date": "July 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01783860", 
            "org_study_id": "90-01-124-13076"
        }, 
        "intervention": [
            {
                "arm_group_label": "Oral Azithromycin", 
                "intervention_name": "Azithromycin", 
                "intervention_type": "Drug", 
                "other_name": "Azithromycin (Razak Co., Tehran)"
            }, 
            {
                "arm_group_label": "Doxycycline", 
                "intervention_name": "Doxycycline", 
                "intervention_type": "Drug", 
                "other_name": "Doxycycline (Kimidarou Co., Tehran)"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Doxycycline", 
                "Doxycycline hyclate", 
                "Azithromycin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Azithromycin", 
            "Doxycycline", 
            "Posterior Blepharitis"
        ], 
        "lastchanged_date": "December 28, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tehran", 
                    "country": "Iran, Islamic Republic of", 
                    "zip": "14455-364"
                }, 
                "name": "Rassoul Akram Hospital"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of the Effect of Oral Azithromycin on Posterior Blepharitis", 
        "other_outcome": [
            {
                "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (7 days) minus earliest time point.", 
                "measure": "Change of Total Severity Score Between Baseline and 7 Days Later", 
                "safety_issue": "No", 
                "time_frame": "baseline and 7 days later"
            }, 
            {
                "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (31 days) minus earliest time point.", 
                "measure": "Change of Total Severity Score Between Baseline and 31 Days Later", 
                "safety_issue": "No", 
                "time_frame": "baseline and 31 days later"
            }, 
            {
                "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (37 days) minus earliest time point.", 
                "measure": "Change of Total Severity Score Between Baseline and 37 Days Later", 
                "safety_issue": "No", 
                "time_frame": "baseline and 37 days later"
            }
        ], 
        "overall_official": {
            "affiliation": "Tehran University of Medical Sciences", 
            "last_name": "Mohsen B Kashkouli, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Five main ocular symptoms of posterior blepharitis (itching, foreign body sensation, dryness, burning, and lid swelling) will be asked of each patient and graded at baseline, and days 7, 31, 37 and 61 after treatment.  For each item there was a question with scale from zero to three (zero for no symptom three for maximum symptom). Therefore, maximum score for symptoms was 15 (worse outcome) and minimum score for symptoms was zero (better outcome). Finally, we reported a change in total score calculated as the latest time point (61 days) minus the earliest time point.", 
                "measure": "Change of Blepharitis Symptoms Score", 
                "safety_issue": "No", 
                "time_frame": "Change from the baseline until 61 days after treatment"
            }, 
            {
                "description": "Total severity score was a combined score of symptoms and signs. For symptoms, there were five items and for signs there were seven items. Each items had three scales form Zero (no symptom) to three (severe symptom). Therefore, there was 12 items to calculate total severity score. Maximum score was 36 (worse outcome) and minimum score was zero (better outcome). A change in total severity score calculated as the latest time period (61 days) minus earliest time point.", 
                "measure": "Change of Symptoms and Signs Scores (Difference Between Total Score of First Time and 61 Days Later), Total Severity Score", 
                "safety_issue": "No", 
                "time_frame": "zero time and 61 days later"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01783860"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "lid margin debris, lid margin redness, Meibomian gland (MG) secretion, occluded MG, conjunctival redness, tear brake up time and ocular surface staining at Baseline, and days 7, 31, 37 and 61 after treatment were measured.  For each items there was a question with scale form zero to three (zero for no sign to three for maximum sign). Therefore, maximum score for signs was 21 (worse outcome) and minimum score was zero (better outcome). We calculated a total score for signs. Finally, we reported a change in total score calculated as the latest time point (61 days) minus earliest time point.", 
            "measure": "Main Ocular Signs", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline until 61 days after treatment"
        }, 
        "source": "Tehran University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tehran University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}